Home
MRSN
MRSN News

Latest Mersana Therapeutics Inc. (MRSN) News on February 23, 2025

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

15 days ago

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

17 days ago

William Blair Initiates Coverage on Mersana Therapeutics With Outperform Rating

Mersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference

GlobeNewswire

24 days ago

Mersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference

MT Newswires

a month ago

Wedbush Cuts Price Target on Mersana Therapeutics to $4 From $7, Keeps Outperform Rating

Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday?

Benzinga

a month ago

Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday?

MT Newswires

a month ago

Mersana Therapeutics' XMT-1660 Gains Additional US FDA Fast Track Designation

MT Newswires

a month ago

Mersana Therapeutics Says Initial Data From Cancer Drug Trial Shows Promise, Shares Rise Premarket

Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)

GlobeNewswire

a month ago

Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)

Mersana Therapeutics Announces Positive Initial Clinical Data from Phase 1 Clinical Trial of Emiltatug Ledadotin (XMT-1660); Initiation of Expansion in Triple Negative Breast Cancer

GlobeNewswire

a month ago

Mersana Therapeutics Announces Positive Initial Clinical Data from Phase 1 Clinical Trial of Emiltatug Ledadotin (XMT-1660); Initiation of Expansion in Triple Negative Breast Cancer

Mersana Therapeutics Inc (MRSN) Q3 2024 Earnings Call Highlights: Strategic Advances and ...

GuruFocus.com

3 months ago

Mersana Therapeutics Inc (MRSN) Q3 2024 Earnings Call Highlights: Strategic Advances and ...

Thomson Reuters StreetEvents

3 months ago

Q3 2024 Mersana Therapeutics Inc Earnings Call

Mersana Therapeutics, Inc. (MRSN) Reports Q3 Loss, Tops Revenue Estimates

Zacks

3 months ago

Mersana Therapeutics, Inc. (MRSN) Reports Q3 Loss, Tops Revenue Estimates

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results

Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024

GlobeNewswire

4 months ago

Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024

SILVERARC CAPITAL MANAGEMENT, LLC Reduces Stake in Mersana Therapeutics Inc

GuruFocus.com

4 months ago

SILVERARC CAPITAL MANAGEMENT, LLC Reduces Stake in Mersana Therapeutics Inc

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Simply Wall St.

6 months ago

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Mersana Therapeutics, Inc. (MRSN) Reports Q2 Loss, Misses Revenue Estimates

Zacks

6 months ago

Mersana Therapeutics, Inc. (MRSN) Reports Q2 Loss, Misses Revenue Estimates

Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results

GlobeNewswire

6 months ago

Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results

Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024

GlobeNewswire

7 months ago

Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024

Mersana Therapeutics (NASDAQ:MRSN) shareholders have endured a 83% loss from investing in the stock three years ago

Simply Wall St.

7 months ago

Mersana Therapeutics (NASDAQ:MRSN) shareholders have endured a 83% loss from investing in the stock three years ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

8 months ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

8 months ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

8 months ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

8 months ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

8 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

8 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

8 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

8 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

8 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

8 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

8 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

8 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

8 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

8 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PR Newswire

8 months ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

8 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

See's Candies® Launches New Scotchmallow® Littles

PR Newswire

9 months ago

See's Candies® Launches New Scotchmallow® Littles

Stock futures slip as markets digest hot jobs data

Yahoo Finance Video

9 months ago

Stock futures slip as markets digest hot jobs data

SOUTHWEST AIRLINES RANKED TOP AIRLINE ON FORBES AMERICA'S BEST EMPLOYERS FOR VETERANS LIST

PR Newswire

9 months ago

SOUTHWEST AIRLINES RANKED TOP AIRLINE ON FORBES AMERICA'S BEST EMPLOYERS FOR VETERANS LIST

IBHS honors resilient construction trailblazers

PR Newswire

9 months ago

IBHS honors resilient construction trailblazers

Lyft Stock Rides High On Bullish Double-Upgrade After Company Offers New Growth Targets

Investor's Business Daily

9 months ago

Lyft Stock Rides High On Bullish Double-Upgrade After Company Offers New Growth Targets

Benzinga

9 months ago

Bill Gates Could Be The World's First Trillionaire If He Had 'Diamond Handed' His Microsoft Shares — He'd Be Sitting On $1.47 Trillion Today

Kohler Mira Ltd. Celebrates Mental Health Awareness Week in the UK: Promoting Wellbeing and Sharing Healthy Habits

ACCESSWIRE

9 months ago

Kohler Mira Ltd. Celebrates Mental Health Awareness Week in the UK: Promoting Wellbeing and Sharing Healthy Habits

Argus Research Updated Equity Report Coverage On Tego Cyber Inc.

ACCESSWIRE

9 months ago

Argus Research Updated Equity Report Coverage On Tego Cyber Inc.

Mersana Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire

9 months ago

Mersana Therapeutics to Present at Upcoming Investor Conferences

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Simply Wall St.

9 months ago

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2024 Earnings Call Transcript

Insider Monkey

9 months ago

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2024 Earnings Call Transcript

GuruFocus.com

9 months ago

Mersana Therapeutics Inc (MRSN) Reports Q1 2024 Financial Results: A Detailed Analysis

Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Misses Revenue Estimates

Zacks

9 months ago

Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Misses Revenue Estimates

Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results

GlobeNewswire

9 months ago

Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024

GlobeNewswire

10 months ago

Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024

Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?

Zacks

a year ago

Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript

An Intrinsic Calculation For Mersana Therapeutics, Inc. (NASDAQ:MRSN) Suggests It's 26% Undervalued

Simply Wall St.

a year ago

An Intrinsic Calculation For Mersana Therapeutics, Inc. (NASDAQ:MRSN) Suggests It's 26% Undervalued

Mersana Therapeutics Full Year 2023 Earnings: Revenues Disappoint

Simply Wall St.

a year ago

Mersana Therapeutics Full Year 2023 Earnings: Revenues Disappoint

Thomson Reuters StreetEvents

a year ago

Q4 2023 Mersana Therapeutics Inc Earnings Call

Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Lags Revenue Estimates

Zacks

a year ago

Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Lags Revenue Estimates

Mersana Therapeutics Inc (MRSN) Reports Fourth Quarter and Full Year 2023 Financial Results

GuruFocus.com

a year ago

Mersana Therapeutics Inc (MRSN) Reports Fourth Quarter and Full Year 2023 Financial Results

Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

a year ago

Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results

Mersana Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire

a year ago

Mersana Therapeutics to Present at Upcoming Investor Conferences

Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

a year ago

Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: Should You Buy?

Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024

GlobeNewswire

a year ago

Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024

Mersana Therapeutics, Inc. (MRSN) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Zacks

a year ago

Mersana Therapeutics, Inc. (MRSN) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

5 Value Stock Buying Opportunities

Zacks

a year ago

5 Value Stock Buying Opportunities

Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference

GlobeNewswire

a year ago

Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference

Is 2024 the Year for Utilities Stocks? 3 Top Sector Picks

InvestorPlace

a year ago

Is 2024 the Year for Utilities Stocks? 3 Top Sector Picks

Is LSI Industries Inc. (NASDAQ:LYTS) Trading At A 44% Discount?

Simply Wall St.

a year ago

Is LSI Industries Inc. (NASDAQ:LYTS) Trading At A 44% Discount?

Isabeau Levito edges Amber Glenn in figure skating nationals short program

NBC Sports

a year ago

Isabeau Levito edges Amber Glenn in figure skating nationals short program

Independent Bank Corporation Reports 2023 Fourth Quarter Results

GlobeNewswire

a year ago

Independent Bank Corporation Reports 2023 Fourth Quarter Results

The past five years for Oil States International (NYSE:OIS) investors has not been profitable

Simply Wall St.

a year ago

The past five years for Oil States International (NYSE:OIS) investors has not been profitable

BlackBerry Stock Is Tumbling Tuesday: What's Going On?

Benzinga

a year ago

BlackBerry Stock Is Tumbling Tuesday: What's Going On?

NGL Energy Partners LP Announces $2.1 Billion Offering of Senior Secured Notes

Business Wire

a year ago

NGL Energy Partners LP Announces $2.1 Billion Offering of Senior Secured Notes

11 Best MLP Dividend Stocks To Buy

Insider Monkey

a year ago

11 Best MLP Dividend Stocks To Buy

CrossAmerica Partners LP Maintains Quarterly Distribution

GlobeNewswire

a year ago

CrossAmerica Partners LP Maintains Quarterly Distribution

Metropolitan Bank Holding Corp. (MCB) Q4 Earnings Miss Estimates

Zacks

a year ago

Metropolitan Bank Holding Corp. (MCB) Q4 Earnings Miss Estimates

Clearlake Completes Exit of its Investment in Janus International

PR Newswire

a year ago

Clearlake Completes Exit of its Investment in Janus International

Saucony Calls on Consumers to Move their Feet More than their Feed with the Launch of the Marathumb Challenge

CNW Group

a year ago

Saucony Calls on Consumers to Move their Feet More than their Feed with the Launch of the Marathumb Challenge

Riley Permian Declares Quarterly Cash Dividend and Reports Debt Reduction

PR Newswire

a year ago

Riley Permian Declares Quarterly Cash Dividend and Reports Debt Reduction

Silvercorp Provides Update on OreCorp Transaction

PR Newswire

a year ago

Silvercorp Provides Update on OreCorp Transaction

Crinetics Pharmaceuticals Inc Insider Sells Shares

GuruFocus.com

a year ago

Crinetics Pharmaceuticals Inc Insider Sells Shares

Insider Stock Buying Reaches US$527.5k On Avid Bioservices

Simply Wall St.

a year ago

Insider Stock Buying Reaches US$527.5k On Avid Bioservices

Bears are Losing Control Over Simulations Plus (SLP), Here's Why It's a 'Buy' Now

Zacks

a year ago

Bears are Losing Control Over Simulations Plus (SLP), Here's Why It's a 'Buy' Now

Wall Street Analysts Predict an 111.38% Upside in Prime Medicine, Inc. (PRME): Here's What You Should Know

Zacks

a year ago

Wall Street Analysts Predict an 111.38% Upside in Prime Medicine, Inc. (PRME): Here's What You Should Know

Shoe Carnival Inc's Dividend Analysis

GuruFocus.com

a year ago

Shoe Carnival Inc's Dividend Analysis

Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?

Mersana Therapeutics Announces Business Updates, Expected 2024 Milestones and Upcoming Presentation at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Mersana Therapeutics Announces Business Updates, Expected 2024 Milestones and Upcoming Presentation at the 42nd Annual J.P. Morgan Healthcare Conference

Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer

GlobeNewswire

a year ago

Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer

Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO

Zacks

a year ago

Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO

Here's Why Investors Should Retain Royal Caribbean (RCL) Now

Zacks

a year ago

Here's Why Investors Should Retain Royal Caribbean (RCL) Now

Kevin Guest Names 2024 the Year of Connection

CNW Group

a year ago

Kevin Guest Names 2024 the Year of Connection

PR Newswire

a year ago

Heidrick & Struggles Announces 2024 Global and Regional Leader Appointments

The past three years for Mersana Therapeutics (NASDAQ:MRSN) investors has not been profitable

Simply Wall St.

a year ago

The past three years for Mersana Therapeutics (NASDAQ:MRSN) investors has not been profitable

Zacks Industry Outlook Highlights Norsk Hydro ASA, AB SKF, ESAB, Century Aluminum and TriMas

Zacks

a year ago

Zacks Industry Outlook Highlights Norsk Hydro ASA, AB SKF, ESAB, Century Aluminum and TriMas

Altus Power Announces Closing of 121 Megawatts in Solar Assets from Basalt and Soltage

Business Wire

a year ago

Altus Power Announces Closing of 121 Megawatts in Solar Assets from Basalt and Soltage

4 Steel Stocks That Have Gained More Than 30% This Year

Zacks

a year ago

4 Steel Stocks That Have Gained More Than 30% This Year

Open Lending Publishes Inaugural ESG Report

GlobeNewswire

a year ago

Open Lending Publishes Inaugural ESG Report

IMAX Corporation's (NYSE:IMAX) Business Is Trailing The Industry But Its Shares Aren't

Simply Wall St.

a year ago

IMAX Corporation's (NYSE:IMAX) Business Is Trailing The Industry But Its Shares Aren't

NexPoint Residential Trust, Inc. Completes the Sale of Timber Creek and Further Paydown of the Corporate Credit Facility

PR Newswire

a year ago

NexPoint Residential Trust, Inc. Completes the Sale of Timber Creek and Further Paydown of the Corporate Credit Facility

Share on Social Networks: